New Study Validates Payer/Physician Use of AI to Cut Wasteful Spending on High-Cost, Low-Value Cancer Drugs
Healthcare AI can guide drug selection to improve effectiveness, avoid waste and drive value for payers and patients.
United States Richardl Nicholas Richard Nicholas Duke University Graduate School Of Business International Committee Research Consortium
Source: einnews.com